Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
"Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has b...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0314828 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839634413018677248 |
---|---|
author | Karine Fouth Tchos Renée Ridzon Mory Cherif Haidara Djeneba Dabitao Esther Akpa Daouda Camara David Vallée Mariam Coulibaly Sekou Camara Jamila Aboulhab Mahamadou Diakité Bassirou Diarra Samba Diarra Ilo Dicko Alyson Francis Cécé Francis Kolié Michel Koropogui Caeul Lim Seydou Samaké Sally Hunsberger Moussa Sidibé Ray Y Chen Issa Konate Seydou Doumbia Abdoul Habib Beavogui Kathryn Shaw-Saliba |
author_facet | Karine Fouth Tchos Renée Ridzon Mory Cherif Haidara Djeneba Dabitao Esther Akpa Daouda Camara David Vallée Mariam Coulibaly Sekou Camara Jamila Aboulhab Mahamadou Diakité Bassirou Diarra Samba Diarra Ilo Dicko Alyson Francis Cécé Francis Kolié Michel Koropogui Caeul Lim Seydou Samaké Sally Hunsberger Moussa Sidibé Ray Y Chen Issa Konate Seydou Doumbia Abdoul Habib Beavogui Kathryn Shaw-Saliba |
author_sort | Karine Fouth Tchos |
collection | DOAJ |
description | "Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has been shown to result in a loss of pre-existing immunity (immune amnesia). MeV-induced immune amnesia has not been studied in West Africa where continual MeV outbreaks occur. Additionally previous studies have relied on naturally occurring exposures to viruses to examine the immune systems ability to create antibodies. Thus, the overall goal of this protocol is to investigate the impact of MeV infection on pre-existing immunity to endemic pathogens in West Africa, observe the effect of a subsequent exposure to a novel pathogen (rabies vaccine), and measure the frequency of subsequent healthcare visits. A total of 256 children aged 1-15 years are being enrolled into one of two study arms: those with acute MeV infection (cases) as confirmed by laboratory testing and without (controls). Controls must be immune to MeV (have IgG). Blood samples are collected at multiple time points including screening (Day 0), at an optional visit to repeat IgM serology for inconclusive or negative Day 0 results (Day 7-10), and during follow-up visits on Day 14, Week 13, and Week 52. These blood samples will be tested to evaluate both humoral and cellular immune responses to a panel of viruses, bacteria, and parasites, including pathogens endemic to West Africa. To explore how recent MeV infection may affect the child's ability to respond to a new exposure, all participants will receive a rabies vaccine (as a controlled stimulus) at one of two timepoints post Day 0 visit. Biological samples will be collected after vaccination to assess if the rabies vaccine response differs: 1) between cases and controls, and 2) based on the time since acute MeV infection. In addition, the study team will collect information on healthcare encounters during the year-long follow-up to determine if there is a difference in the number of encounters by study group. The findings of this study will further the understanding of the MeV immune amnesia phenotype by understanding its impact on endemic pathogens and subsequent immune response following infection. |
format | Article |
id | doaj-art-4e92216ed87e4819b53d3db2bc7f35d4 |
institution | Matheson Library |
issn | 1932-6203 |
language | English |
publishDate | 2025-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj-art-4e92216ed87e4819b53d3db2bc7f35d42025-07-10T05:31:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01206e031482810.1371/journal.pone.0314828Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.Karine Fouth TchosRenée RidzonMory Cherif HaidaraDjeneba DabitaoEsther AkpaDaouda CamaraDavid ValléeMariam CoulibalySekou CamaraJamila AboulhabMahamadou DiakitéBassirou DiarraSamba DiarraIlo DickoAlyson FrancisCécé Francis KoliéMichel KoropoguiCaeul LimSeydou SamakéSally HunsbergerMoussa SidibéRay Y ChenIssa KonateSeydou DoumbiaAbdoul Habib BeavoguiKathryn Shaw-Saliba"Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has been shown to result in a loss of pre-existing immunity (immune amnesia). MeV-induced immune amnesia has not been studied in West Africa where continual MeV outbreaks occur. Additionally previous studies have relied on naturally occurring exposures to viruses to examine the immune systems ability to create antibodies. Thus, the overall goal of this protocol is to investigate the impact of MeV infection on pre-existing immunity to endemic pathogens in West Africa, observe the effect of a subsequent exposure to a novel pathogen (rabies vaccine), and measure the frequency of subsequent healthcare visits. A total of 256 children aged 1-15 years are being enrolled into one of two study arms: those with acute MeV infection (cases) as confirmed by laboratory testing and without (controls). Controls must be immune to MeV (have IgG). Blood samples are collected at multiple time points including screening (Day 0), at an optional visit to repeat IgM serology for inconclusive or negative Day 0 results (Day 7-10), and during follow-up visits on Day 14, Week 13, and Week 52. These blood samples will be tested to evaluate both humoral and cellular immune responses to a panel of viruses, bacteria, and parasites, including pathogens endemic to West Africa. To explore how recent MeV infection may affect the child's ability to respond to a new exposure, all participants will receive a rabies vaccine (as a controlled stimulus) at one of two timepoints post Day 0 visit. Biological samples will be collected after vaccination to assess if the rabies vaccine response differs: 1) between cases and controls, and 2) based on the time since acute MeV infection. In addition, the study team will collect information on healthcare encounters during the year-long follow-up to determine if there is a difference in the number of encounters by study group. The findings of this study will further the understanding of the MeV immune amnesia phenotype by understanding its impact on endemic pathogens and subsequent immune response following infection.https://doi.org/10.1371/journal.pone.0314828 |
spellingShingle | Karine Fouth Tchos Renée Ridzon Mory Cherif Haidara Djeneba Dabitao Esther Akpa Daouda Camara David Vallée Mariam Coulibaly Sekou Camara Jamila Aboulhab Mahamadou Diakité Bassirou Diarra Samba Diarra Ilo Dicko Alyson Francis Cécé Francis Kolié Michel Koropogui Caeul Lim Seydou Samaké Sally Hunsberger Moussa Sidibé Ray Y Chen Issa Konate Seydou Doumbia Abdoul Habib Beavogui Kathryn Shaw-Saliba Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. PLoS ONE |
title | Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. |
title_full | Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. |
title_fullStr | Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. |
title_full_unstemmed | Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. |
title_short | Investigating immune amnesia after measles virus infection in two West African countries: A study protocol. |
title_sort | investigating immune amnesia after measles virus infection in two west african countries a study protocol |
url | https://doi.org/10.1371/journal.pone.0314828 |
work_keys_str_mv | AT karinefouthtchos investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT reneeridzon investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT morycherifhaidara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT djenebadabitao investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT estherakpa investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT daoudacamara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT davidvallee investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT mariamcoulibaly investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT sekoucamara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT jamilaaboulhab investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT mahamadoudiakite investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT bassiroudiarra investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT sambadiarra investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT ilodicko investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT alysonfrancis investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT cecefranciskolie investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT michelkoropogui investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT caeullim investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT seydousamake investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT sallyhunsberger investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT moussasidibe investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT rayychen investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT issakonate investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT seydoudoumbia investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT abdoulhabibbeavogui investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol AT kathrynshawsaliba investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol |